World Collagen Conference

06th – 07th September, 2017
London, United Kingdom

OverviewAgendaPresentersRegisterVenueContact

“Outlook on the Global Collagen Market”

Global collagen market is anticipated to reach US$ 9,372.3 Mn by 2023, expanding at a CAGR of 9.4% during the forecast period from 2015 to 2023.

Asia-Pacific is forecast to emerge as the fastest growing market with a CAGR of 9.1% by 2020.

 

About the Event

Increasing consumer consciousness towards health and personal care coupled with rising trend for nutraceutical products are expected to fuel the growth of Collagen. Improving standard of living and growing fitness consciousness are likely to be the key drivers to propel demand. Global collagen market size was valued at more than USD 3 billion in 2015 and is likely to exceed USD 5 billion by 2023, growing at a CAGR of more than 7% from 2016 to 2023.

Gelatin market size, which is a collagen byproduct, dominated overall revenue and accounted for more than 60% of the total collagen market share in 2015, it was valued at more than USD 2.5 billion and is expected to exceed USD 2.8 billion by 2023. Collagen peptides market size was valued at more than USD 0.75 billion in 2015 and is likely to be worth around USD 1.25 billion by the end the forecast period.

Marine collagen market size was valued at more than USD 200 million in 2015; minimal disease transmission risk and relaxed regional and social regulations are expected to be the key factors driving growth. In terms of application, cosmetics were the major contributor, with total volume of over 4.2 kg tonnes in 2015 owing to benefits such as anti aging properties and personal & hygiene products demand.

The gelatin market is dominated by Europe, and is likely to grow at a significant rate due to the growth in end-use industries such as food & beverages and pharmaceuticals. Asia-Pacific is anticipated grow at a high rate due to increase in per capita income and fast-paced industrialization.

Applications can be segmented into cosmetics, food & beverages, nutraceuticals, healthcare and pharmaceuticals. Food & beverages can be further bifurcated into beer, wine, cakes, jellies, ice-creams, refined sugar, and non-dairy creamer. Increase in consumption and growing food industry is likely to contribute to industry growth.

Nutraceuticals and pharmaceutical sector is anticipated to grow at a higher rate owing to the vast applications in these segments. Healthcare includes orthopedic, dental and surgery procedures, wherein collagen helps in constructing artificial skin in order to heal burns and wounds. Increasing geriatric population accompanied by increasing problems related to the skin and bones is expected to the boost demand. Increasing healthcare spending among consumers accompanied by FDA & IMA approvals for gelatin to be used in drugs and food preservatives has also fueled growth.

The collagen industry is characterized by increasing R&D activities for drug development, rising social awareness about personal health, and growing wound healing & regenerative medicines industry. Increasing food grades prices and huge importing cost is likely to restrain growth.

The World Collagen Conference will discuss the industry’s growth forecast, analyse the regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants, the leading market products, applications & regions and how will they perform, the technology & innovation trends, how will they evolve, highlight how companies are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook.

 
KEY HIGHLIGHTS
  • An overview of global collagen market
  • The market size and the growth rate of collagen products by 2023
  • Visualisation of newly synthesised collagen in vitro and in vivo

  • Outlining Innovations and advancements in collagen production

  • Gene regulation and functional aspects of collagen biosynthesis
  • The diversity of collagens in development, disease and tissue repair
 
 

KEEPING UP WITH THE INDUSTRY’S VIEWS

MINERVA RESEARCH LABS Presents New Research at The World Collagen Conference

Posted on: 06 September 2017

Pioneers in nutricosmeceuticals, MINERVA Research Labs, are pleased to announce their participation at the World Collagen Conference on 6–7 September 2017, taking place at The Hilton London Tower Bridge, London. Dr. Martin Godfrey, Independent Medical Consultant at Minerva Research Labs will be discussing the benefits of GOLD COLLAGEN® products on skin health (Innovative Nutraceutical Approaches to Promote Healthy Ageing - Beauty and Wellness from Within). He will also be presenting the latest findings from a recent clinical trial conducted by Minerva Research Labs in collaboration with MedicalSpa, an independent aesthetic clinic based in Rome. The study looked into changes in skin texture following dietary supplementation of collagen bioactive peptides and antioxidants. The results were recently published in the prestigious scientific journal Skin Pharmacology & Physiology. Dr. Martin Godfrey has also been requested to introduce and address the Conference as Chairman in the morning session on the 6th of September.

Dr. Martin’s speech will be followed by a talk from Russelot’s discussing the beneficial effects of Peptan® collagen peptides, present in GOLD COLLAGEN® products, on skeletal muscles and joints.

The World Collagen Conference will discuss the growth forecast, analyse the regulatory trends, drivers, pitfalls, challenges in the food supplement industry. It will look at the growth opportunities for participants, the leading market products, applications & regions and how they perform. Highlighting also the technology & innovation trends, how they evolve and how companies are positioned in the market in terms of sustainability, competency, production capacity and strategic outlook.

About Minerva Research Labs

Created in 2009, MINERVA Research Labs has become a recognised health and beauty company by launching innovativ brands that fundamentally challenge the way consumers look at nutritional supplements and beauty regimes. Understanding the growing interest for healthy nutrition, Tony Sanguinetti was convinced that “you are what you eat and drink” is more than a simple statement and could be the underlying vision of a new holistic approach to health and beauty. Pioneering the collagen based liquid beauty supplement category, this scientifically developed, clinically tested and carefully formulated range reinvents skincare and nutraceuticals to fit in with modern lifestyles.

Dedicated to producing only high quality effective products, they collaborate with renowned universities, gold standard testing facilities, suppliers and manufacturers to deliver clinically tested and scientifically developed products all made with three fundamental attributes: research, high quality and efficacy. In 2015 PURE GOLD COLLAGEN® was granted a European patent for its advanced ingredient complex within its formulation.

The GOLD COLLAGEN® liquid supplement range includes PURE GOLD COLLAGEN®, PURE GOLD COLLAGEN® MINI, ACTIVE GOLD COLLAGEN®, GOLD COLLAGEN® FORTE and GOLD COLLAGEN® RX. The portfolio also includes GOLD COLLAGEN® DEFENCE tablets, specifically formulated to help protect against collagen loss and GOLD COLLAGEN® HYDROGEL MASK for dehydrated, tired-looking skin.

MINERVA Research Labs Ltd is one of the London Stock Exchange Group’s ELITE programme. MINERVA Research Labs Ltd has been recognised as a major contributor to the UK export market in the third prestigious Sunday Times Lloyds SME Export Track 100 by being placed at No. 26 in the ranking 2017.

 

 

CONFERENCE AGENDA*

WORLD COLLAGEN CONFERENCE 
06-07 September, 2017
London, United Kingdom

Day 1: 06th September, 2017
 
8.30 AM REGISTRATION & COFFEE
9.30 AM CHAIRMAN’S WELCOME REMARKS
 9.45 AM
Benefits of Fish Collagen Peptides for Healthy Skin Ageing and Weight Management

 

 

 Presenter: 

 

Dr Christelle BONNET
Innovation/Preclinical and Clinical Research manager
Weishardt


 10.45 AM
Probing into Benefits of Using Hydrolyzed Collagen as a Cosmetic Ingredient

 

  Presenter:
Dr. Martin Godfrey
Independent Medical Consultant
Minerva Research Labs


11.45 AM Morning Coffee Break & Networking
 12.15 PM
Oral Collagen Peptides for Healthy and Active Ageing: Evidence for Benefits from Skin beauty to Musculoskeletal Health

 

  Presenter:
Dr Janne Prawitt
Principal Scientist–Nutrition
Rousselot


1.15 PM Networking Lunch
 2.30 PM
Pangasius – A Comprehensive Outlook on the Emerging Source of Collagen.

 

  Presenter:

Dr. Annie Vo
Independent R&D Consultant
Vinh Hoan Corp.

3.30 PM Afternoon Coffee Break & Networking
 4.00 PM
Comprehending the Burgeoning Role of Collagen Supplements in Healthcare and Skincare Industry

 

  Presenter:
Asma Ishaq
President, Collagen Sciences & Chief Industry Relations Officer
Modere


 5.00 PM Q&A
5.30 PM End of Day 1
 
Day 2: 07th September, 2017
 10.00 AM
Looking into Production of Hydrolysed Collagen from Fishery By-products

 

  Presenter:
Margrét Geirsdóttir
Project Manager
Matis


10.30 AM Morning Coffee Break & Networking
 11.00 AM
The Use of Collagen Hydrolysate by Elite Athletes and the Potential Impact for Sport

 

  Presenter:

James Greenwell
Managing Director
Proto-Col

 12.00 PM
Area for Growth in Skin Care – Probing into Latest Collagen Formulations Enhancing Skin care

 

  Presenter:

Steffen Oesser
Founder
Collagen Research Institute

1.00 PM Networking Lunch

*Agenda content and timeline subject to change.

 

KEEPING UP WITH THE INDUSTRY’S VIEWS

MINERVA RESEARCH LABS Presents New Research at The World Collagen Conference

Posted on: 06 September 2017

Pioneers in nutricosmeceuticals, MINERVA Research Labs, are pleased to announce their participation at the World Collagen Conference on 6–7 September 2017, taking place at The Hilton London Tower Bridge, London. Dr. Martin Godfrey, Independent Medical Consultant at Minerva Research Labs will be discussing the benefits of GOLD COLLAGEN® products on skin health (Innovative Nutraceutical Approaches to Promote Healthy Ageing - Beauty and Wellness from Within). He will also be presenting the latest findings from a recent clinical trial conducted by Minerva Research Labs in collaboration with MedicalSpa, an independent aesthetic clinic based in Rome. The study looked into changes in skin texture following dietary supplementation of collagen bioactive peptides and antioxidants. The results were recently published in the prestigious scientific journal Skin Pharmacology & Physiology. Dr. Martin Godfrey has also been requested to introduce and address the Conference as Chairman in the morning session on the 6th of September.

Dr. Martin’s speech will be followed by a talk from Russelot’s discussing the beneficial effects of Peptan® collagen peptides, present in GOLD COLLAGEN® products, on skeletal muscles and joints.

The World Collagen Conference will discuss the growth forecast, analyse the regulatory trends, drivers, pitfalls, challenges in the food supplement industry. It will look at the growth opportunities for participants, the leading market products, applications & regions and how they perform. Highlighting also the technology & innovation trends, how they evolve and how companies are positioned in the market in terms of sustainability, competency, production capacity and strategic outlook.

About Minerva Research Labs

Created in 2009, MINERVA Research Labs has become a recognised health and beauty company by launching innovativ brands that fundamentally challenge the way consumers look at nutritional supplements and beauty regimes. Understanding the growing interest for healthy nutrition, Tony Sanguinetti was convinced that “you are what you eat and drink” is more than a simple statement and could be the underlying vision of a new holistic approach to health and beauty. Pioneering the collagen based liquid beauty supplement category, this scientifically developed, clinically tested and carefully formulated range reinvents skincare and nutraceuticals to fit in with modern lifestyles.

Dedicated to producing only high quality effective products, they collaborate with renowned universities, gold standard testing facilities, suppliers and manufacturers to deliver clinically tested and scientifically developed products all made with three fundamental attributes: research, high quality and efficacy. In 2015 PURE GOLD COLLAGEN® was granted a European patent for its advanced ingredient complex within its formulation.

The GOLD COLLAGEN® liquid supplement range includes PURE GOLD COLLAGEN®, PURE GOLD COLLAGEN® MINI, ACTIVE GOLD COLLAGEN®, GOLD COLLAGEN® FORTE and GOLD COLLAGEN® RX. The portfolio also includes GOLD COLLAGEN® DEFENCE tablets, specifically formulated to help protect against collagen loss and GOLD COLLAGEN® HYDROGEL MASK for dehydrated, tired-looking skin.

MINERVA Research Labs Ltd is one of the London Stock Exchange Group’s ELITE programme. MINERVA Research Labs Ltd has been recognised as a major contributor to the UK export market in the third prestigious Sunday Times Lloyds SME Export Track 100 by being placed at No. 26 in the ranking 2017.

 

 

   

James Greenwell
Managing Director
Proto-Col

James Greenwell, founder of proto-col and former captain of the GB Modern Pentathlon Team, managed to turn a career-threatening injury into a brilliant business opportunity. James Greenwell was a part of GB modern Pentathlon team 1990-2000. He won over 50 International caps for GB. James has also competed at junior and senior world championships, senior European Championships, was short listed for Olympic team 1996/2000. He was a part of the British men’s team captain 2001/2002.

James founded proto-col beauty & Nutrition in 2003, and at present the Global retail turnover of brand is excess of £20 million. He returned to sport in September 2012.
Associations:
GB biathle team (run/swim/run) 2013-present.
British Masters Champion 2013,14,15,16,17
European Biathle champion 2015
Masters World Ranked no 1 – 2013,14,15,16
World Championship 2nd – 2015, 3rd – 2016.
GB Triathle team 2017 (shoot,swim,run)
British Champion 2017
European Champion 2017
GB Aquathon team 2016
(swim 1km open water, 5km run)
GB Triathlon Association
2016 – 2nd British National Championships
European team 2016
2017 – National Champion!
Presently building towards the WorldChampionship in Viverio – Spain September 20-25th 2017.

Dr. Annie Vo
Independent R&D Consultant
Vinh Hoan Corp

Dr. Annie Vo received her Bachelor degree in Biology from Massachusetts Institute of Technology and her Ph.D. in Biological & Biomedical Sciences from Harvard University. Her scientific experience was primarily in cancer research, having been in both research institution and pharmaceutical. She had investigated the mechanism of breast cancer metastasis in the lab of Dr. Robert Weinberg at Whitehead Institute prior to researching novel therapy for colon cancer at Merck & Co. Her dissertation analyzed abnormal glucose metabolism in cancer cells. 

After completing her Ph.D., Dr. Vo shifted focus to her long-time interest in food, nutrition and their therapeutic values. In the past 5 years, she has been helping small, innovative companies with their scientific challenges. She joined Vinh Hoan Corp. as an independent R&D Consultant in 2015, where she currently oversees clinical study on the health benefits of Vinh Wellness Collagen.

 

Asma Ishaq
President, Collagen Sciences
&
Chief Industry Relations Officer
Modere

Asma Ishaq has united experience and vision to establish innovative concepts in health and beauty industries. Asma founded an award-winning company with an award-winning product line based on multi-patented Liquid BioCell® nutraceutical ingredient that has pioneered the collagen and hyaluronic acid dietary supplement and skincare markets. Her company both maintained high standards in business ethics across distribution channels and industries while championing new product technology.

Her extensive background in product development, formulation, skincare and nutritional supplement manufacturing well-prepared her to be founder and president of Modere’s Collagen Sciences division, and serve as the company’s Chief Industry Relations Officer. Before starting her own company in 2009, she held executive positions at BioCell Technology and GMP Laboratories. Asma serves the direct-selling channel on the DSA Board of Directors, the nutrition industry as a Committee Member on the Council of Responsible Nutrition and is on the advisory panel of the International Fragrance Association of North America (IFRANA). Also a celebrated speaker, Asma has spoken at dozens of conferences, tv shows, and radio programs. She earned her B.A. from the University of California, Berkeley and received a dual M.B.A. in finance and marketing from Rice University.

Dr Christelle BONNET
Innovation/Preclinical and clinical Research manager,
Weishardt

Christelle BONNET followed her classes in the French education system with a Masters degree in Biology/ Nutrition from the Engineering school of Montpellier and a PhD in Biology and Biotechnology. After receiving her Masters degree, Christelle worked for over 5 years in the food industry as a R&D manager. As she wanted to learn more about how active compounds may show their bio-functionalities, she embarked on a PhD, researching the effects of polyphenols (dopamine, leucocyanidine, etc) and phystosterols (sitoindosides) from Musa cavendish on cardiovascular and anti-ulcerogenic activities. The French Research Ministry awarded Christelle an Innovation Prize for her work in this area.

Seven years ago, Christelle joined Weishardt in order to support scientific and technical development of Naticol®, fish collagen peptides.  She is now responsible for the coordination of clinical and preclinical scientific studies in order to develop and investigate a portfolio of fish collagen peptides (Naticol®) for food, nutraceutical, pharmaceutical industries in relation to their health benefits. Her main responsibilities include design and monitoring preclinical and clinical research, writing literature reports and scientific articles, public and private collaborations, financial support implementation (FEDER/ Région),intellectual property. More recently, Christelle contributed as an inventor in the conception of the main ideas in the patent claims of a patent therapeutic application.

 

Dr Martin Godfrey
Independent Medical Consultant
Minerva Research Labs

Dr Martin Godfrey has over 25 years’ experience working in the health sector. His key areas of expertise lie in the nutraceutical and pharmaceutical research, and marketing communications. Martin collaborates with MINERVA Research Labs R&D team who in turn are focused on developing robust clinical and scientific research in partnership with leading academic institutes around the world.

The team has so far published 8 original research articles in peer-reviewed journals and have a healthy pipeline of new studies in progress. Dr Godfrey collaborates with MINERVA Research Labs since 2014 having worked previously in medical and marketing communications companies such as Ogilvy and Mather and Hill and Knowlton. His expertise in the field developed through his work first with Raisio in Finland, then McNeil (J&J) in the development and scientific communication of Benecol in Europe.

Martin now writes and lectures regularly on anti-ageing and aesthetics, most recently authoring a series of leaders in the Aesthetics Journal. Martin qualified in medicine at Birmingham University.

 

Dr Janne Prawitt
Principal Scientist–Nutrition
Rousselot

Dr Janne Prawitt is the Principal Scientist – Nutrition at Rousselot where she is responsible for the Nutrition and Health Science portfolio supporting Peptan®, Rousselot’s collagen peptides. A nutritional scientist by education she has spent 10 years in academic research in Germany and France, investigating mechanisms that contribute to the development of metabolic diseases such as obesity and diabetes. Janne joined Rousselot in 2013, where her main interest is to understand the benefit of collagen peptides for musculoskeletal health and skin physiology, and to develop related products for the global market.

 

Margrét Geirsdóttir
Project Manager
Matís

Margrét Geirsdóttir is a project manager at Matís – Icelandic Food and Biotech R&D. She has been working at Matis – previously Icelandic Fisheries Laboratories – from 1998 were her main research areas have been utilization of fish proteins from underutilized raw materials, extraction, functional properties, hydrolysation and bioactive properties. In the past two years her main focus has been on isolation and hydrolysation of collagen from fish skin.

Steffen Oesser
Founder
Collagen Research Institute

Steffen Oesser studied biology and chemistry at the University of Kiel in Germany. As a Scientific Assistant at the Institute for Physiology of the University of Kiel, he initially concentrated on the areas of cell physiology and protein chemistry. Since 1993, Dr. Oesser has been active in medical research at the Hospital for General and Thoratic Surgery at the Kiel campus of the University Hospital of Schleswig-Holstein, Germany. He is principally involved in researching the pathophysiology of osteoarthritis and the development of new therapy possibilities for the treatment of degenerative disease of joint cartilage. Since October 2003, Dr Oesser is Director of the Collagen Research Institute (CRI) in Kiel, Germany.

 

KEEPING UP WITH THE INDUSTRY’S VIEWS

MINERVA RESEARCH LABS Presents New Research at The World Collagen Conference

Posted on: 06 September 2017

Pioneers in nutricosmeceuticals, MINERVA Research Labs, are pleased to announce their participation at the World Collagen Conference on 6–7 September 2017, taking place at The Hilton London Tower Bridge, London. Dr. Martin Godfrey, Independent Medical Consultant at Minerva Research Labs will be discussing the benefits of GOLD COLLAGEN® products on skin health (Innovative Nutraceutical Approaches to Promote Healthy Ageing - Beauty and Wellness from Within). He will also be presenting the latest findings from a recent clinical trial conducted by Minerva Research Labs in collaboration with MedicalSpa, an independent aesthetic clinic based in Rome. The study looked into changes in skin texture following dietary supplementation of collagen bioactive peptides and antioxidants. The results were recently published in the prestigious scientific journal Skin Pharmacology & Physiology. Dr. Martin Godfrey has also been requested to introduce and address the Conference as Chairman in the morning session on the 6th of September.

Dr. Martin’s speech will be followed by a talk from Russelot’s discussing the beneficial effects of Peptan® collagen peptides, present in GOLD COLLAGEN® products, on skeletal muscles and joints.

The World Collagen Conference will discuss the growth forecast, analyse the regulatory trends, drivers, pitfalls, challenges in the food supplement industry. It will look at the growth opportunities for participants, the leading market products, applications & regions and how they perform. Highlighting also the technology & innovation trends, how they evolve and how companies are positioned in the market in terms of sustainability, competency, production capacity and strategic outlook.

About Minerva Research Labs

Created in 2009, MINERVA Research Labs has become a recognised health and beauty company by launching innovativ brands that fundamentally challenge the way consumers look at nutritional supplements and beauty regimes. Understanding the growing interest for healthy nutrition, Tony Sanguinetti was convinced that “you are what you eat and drink” is more than a simple statement and could be the underlying vision of a new holistic approach to health and beauty. Pioneering the collagen based liquid beauty supplement category, this scientifically developed, clinically tested and carefully formulated range reinvents skincare and nutraceuticals to fit in with modern lifestyles.

Dedicated to producing only high quality effective products, they collaborate with renowned universities, gold standard testing facilities, suppliers and manufacturers to deliver clinically tested and scientifically developed products all made with three fundamental attributes: research, high quality and efficacy. In 2015 PURE GOLD COLLAGEN® was granted a European patent for its advanced ingredient complex within its formulation.

The GOLD COLLAGEN® liquid supplement range includes PURE GOLD COLLAGEN®, PURE GOLD COLLAGEN® MINI, ACTIVE GOLD COLLAGEN®, GOLD COLLAGEN® FORTE and GOLD COLLAGEN® RX. The portfolio also includes GOLD COLLAGEN® DEFENCE tablets, specifically formulated to help protect against collagen loss and GOLD COLLAGEN® HYDROGEL MASK for dehydrated, tired-looking skin.

MINERVA Research Labs Ltd is one of the London Stock Exchange Group’s ELITE programme. MINERVA Research Labs Ltd has been recognised as a major contributor to the UK export market in the third prestigious Sunday Times Lloyds SME Export Track 100 by being placed at No. 26 in the ranking 2017.

 

 

 
Delegate
£799
Exhibitor
£1299
 All Conference Session
 Conference Proceedings  
 On-Site Lunches
 Refreshment Breaks
Table-Top Exhibiton Display  
Logo Promotion  
  Register Register 

Register 3 Send 4th One Free Any organization wishing to send multiple attendees to this conference may send 1 FREE for every 3 delegates registered. Please note that all the 3 participants must register at the same time to avail this benefit.

Note: All payments are made in Pounds.
Registration fee only covers cost of all sessions, luncheon, coffee/tea & presentations. Fee does NOT include any travel or accommodation expenses. Fee is not inclusive of 8% Admin/Bank Charges.

Venue

Hilton London Tower Bridge
Address: 5 More London Place, Tooley Street, London SE1 2BY, United Kingdom
Phone: +44 20 3002 4300
Website: http://www3.hilton.com/en/hotels/united-kingdom/hilton-london-tower-bridge-LONTBHI/index.html


Name (required)

Email (required)

Phone Number(with country code): (required)
-

Select Event (required)

Subject

Your Message


 
 

Our Clients